SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-132991
Filing Date
2019-05-01
Accepted
2019-05-01 16:11:57
Documents
7
Period of Report
2019-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d749656d8k.htm 8-K 19752
2 EX-1.1 d749656dex11.htm EX-1.1 197102
3 EX-5.1 d749656dex51.htm EX-5.1 5490
4 EX-99.1 d749656dex991.htm EX-99.1 11605
5 EX-99.2 d749656dex992.htm EX-99.2 11259
6 GRAPHIC g749656g0501081833500.jpg GRAPHIC 4572
7 GRAPHIC g749656g0501082132604.jpg GRAPHIC 5285
  Complete submission text file 0001193125-19-132991.txt   260294
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 19787610
SIC: 2836 Biological Products, (No Diagnostic Substances)